Filter
54
Filtered Results: 54
Text search:
L.
Mofenson
Featured
Recommendations
3
New Publications
4
Language
Document type
No document type
37
Studies & Reports
7
Guidelines
7
Manuals
3
Countries / Regions
Africa
3
Thailand
2
Kenya
2
Zimbabwe
2
Zambia
2
Lesotho
1
Rwanda
1
Cameroon
1
Senegal
1
Malawi
1
Haiti
1
Tanzania
1
Côte d’Ivoire / Ivory Coast
1
Uganda
1
Brazil
1
Ethiopia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
HIV & STI
7
Pediatrics
4
Paediatrics
2
Communicable Diseases
1
COVID-19
1
Demograhic Health Surveys DHS
1
Policies & Guidelines HIV & TB
1
Capacity Building
1
Other
1
Maternal Health
1
TB
1
Toolboxes
Children & Adolescents
14
Treatment & Prevention
12
Clinical Aspects, Treatment & Prevention
5
Antiretroviral Treatment ART
5
General Aspects
4
Opportunistic Infections
3
HIV testing & disclosure
3
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
3
Prevention of mother-to-child transmission (PMTCT)
3
TB/HIV Coinfection
3
Reports & Studies Children HIV
3
Clinical Aspects
2
For Pregnant Women
2
Paediatrics
2
Latin America & the Carribean
2
Epidemiology
2
Reports & Studies
2
ART Drug Resistance
1
HIV testing & services
1
Prevention & Control
1
Prevention Guidelines
1
HIV
1
TB
1
Children/Adolescents Mental Disorders
1
Discrimination & Stigma
1
Clinical Guidelines
1
Gender Aspects
1
TB/HIV
1
Studies & Reports
1
Co-Morbidities (except TB)
1
Nutrition
1
Research & Access
1
HIV and coinfection
1
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
Module 12:
Adolescents and young adults
July 2018
Module 12: Adolescents and young adults. This module is for people who are interested in providing PrEP services to older adolescents and young adults who are at substantial risk for HIV. It provides information on: factors that influence HIV...
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
Review
published: 12 August 2016 doi: 10.3389/fpubh.2016.00166
Frontiers in Public Health | www.frontiersin.org 1 August 2016 | Volume 4 | Article 166
AIDS Research and Therapy 2015, 12:12 (24 April 2015)
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
